Literature DB >> 12031990

Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes.

Yan Feng1, Tianhua Niu, Xin Xu, Changzhong Chen, Qiongfang Li, Rongli Qian, Guoying Wang, Xiping Xu.   

Abstract

In an attempt to examine the role of an ACE gene insertion/deletion (I/D) polymorphism in type 2 diabetes, we conducted a case-control association study among 132 couple-pairs from northern China. The genotype frequencies for II, ID, and DD were 39.8, 39.8, and 20.3%, respectively, in the case group and 44.8, 44.8, and 10.4% in the control group. The DD frequency was significantly higher in the case group than in the control group (chi(2)(1) = 4.77, P = 0.03), suggesting that the DD genotype is associated with an increased susceptibility to type 2 diabetes in our study population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031990     DOI: 10.2337/diabetes.51.6.1986

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

1.  Genetic Predisposition to Diabetic Nephropathy: Evidence for a Role of ACE (I/D) Gene Polymorphism in Type 2 Diabetic Population from Kutch Region.

Authors:  Deepak N Parchwani; Kamlesh M Palandurkar; D Hema Chandan Kumar; Darshan J Patel
Journal:  Indian J Clin Biochem       Date:  2013-11-20

2.  Association of angiotensin I converting enzyme, angiotensin II type 1 receptor and angiotensin I converting enzyme 2 gene polymorphisms with the dyslipidemia in type 2 diabetic patients of Chinese Han origin.

Authors:  Y Xu; Q Bao; B He; Y Pan; R Zhang; X Mao; Z Tang; L Qu; C Zhu; F Tian; S Wang
Journal:  J Endocrinol Invest       Date:  2011-06-07       Impact factor: 4.256

3.  Angiotensin-converting enzyme gene polymorphisms and T2DM in a case-control association study of the Bahraini population.

Authors:  Einas M Al-Harbi; Eman M Farid; Khalid A Gumaa; Emad M Masuadi; Jaipaul Singh
Journal:  Mol Cell Biochem       Date:  2011-01-05       Impact factor: 3.396

4.  Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study.

Authors:  Marguerite R Irvin; Amy I Lynch; Edmond K Kabagambe; Hemant K Tiwari; Joshua I Barzilay; John H Eckfeldt; Eric Boerwinkle; Barry R Davis; Charles E Ford; Donna K Arnett
Journal:  J Hypertens       Date:  2010-10       Impact factor: 4.844

5.  Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteers.

Authors:  Stefan Viktor Vormfelde; Daniel Sehrt; Daniela Bolte; Susanne Pahl; Mladen Tzvetkov; Jürgen Brockmöller
Journal:  Eur J Clin Pharmacol       Date:  2006-02-01       Impact factor: 2.953

Review 6.  Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.

Authors:  André J Scheen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects.

Authors:  Jaime J Jayapalan; Sekaran Muniandy; Siew P Chan
Journal:  Indian J Hum Genet       Date:  2010-05

8.  Angiotensin-converting enzyme gene polymorphism is associated with type 2 diabetes: a meta-analysis.

Authors:  Jian-Bo Zhou; Jin-Kui Yang; Jing-Kai Lu; Yan-Hua An
Journal:  Mol Biol Rep       Date:  2009-08-05       Impact factor: 2.316

9.  Association of angiotensin-converting enzyme insertion/deletion polymorphism with obesity, cardiovascular risk factors and exercise-mediated changes in Korean women.

Authors:  Kijin Kim
Journal:  Eur J Appl Physiol       Date:  2009-01-06       Impact factor: 3.078

10.  Mid-life blood pressure levels and the 8-year incidence of type 2 diabetes mellitus: the Rancho Bernardo Study.

Authors:  C K Kramer; D von Mühlen; E Barrett-Connor
Journal:  J Hum Hypertens       Date:  2009-12-17       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.